UniProt ID | Protein Name | Gene Symbol ▲ | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
H2UYS3 | Angiotensin-converting enzyme |
|
2 | 0 |
|
A0A674MFZ7 | Angiotensin-converting enzyme |
|
2 | 0 |
|
H2UYS5 | Angiotensin-converting enzyme |
|
2 | 0 |
|
Q5NDE4 | Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 |
|
3 | 0 |
|
O93279 | Amyloid-beta A4 protein |
|
1 | 0 |
|
A0A674NTS1 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
Q5CB00 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A674MA33 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
Q5CAZ7 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A674MHB7 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
Q8AV84 | Biotinidase |
|
5 | 0 |
|
P79755 | Complement component C9 |
|
4 | 0 |
|
Q98894 | Cannabinoid receptor type 1A |
|
2 | 0 |
|
Q98895 | Cannabinoid receptor type 1B |
|
2 | 0 |
|
P79750 | Macrophage colony-stimulating factor 1 receptor 1 |
|
9 | 0 |
|
Q8UVR8 | Macrophage colony-stimulating factor 1 receptor 2 |
|
14 | 0 |
|
P53452 | D(1)-like dopamine receptor |
|
1 | 0 |
|
P53453 | D(2)-like dopamine receptor |
|
3 | 0 |
|
P53454 | D(5)-like dopamine receptor |
|
1 | 0 |
|
Q9PUQ8 | Sphingosine 1-phosphate receptor 3 |
|
1 | 0 |
|
H2V7F7 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A674MJK0 | Fibroblast growth factor receptor |
|
8 | 0 |
|
H2V7F6 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A674PB29 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A674NDI9 | Fibroblast growth factor receptor |
|
8 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025